This article is a retraction of:
RETRACTED: Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart
A Retraction of the Original Research Article
Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart
by Chen X, Zhao M-Z, Miao B-P, Liu Z-Q, Yang G, Liu J-Q, Yang P-C and Song J-P (2020) Immunol. 11:1955. doi: 10.3389/fimmu.2020.01955
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Immunology- Inflammation and the Chief Executive Editor of Frontiers. The authors agree to respond to correspondence regarding this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart. Front. Immunol. 14:1227707. doi: 10.3389/fimmu.2023.1227707
Received: 23 May 2023; Accepted: 23 May 2023;
Published: 05 June 2023.
Approved by:
Pietro Ghezzi, University of Urbino Carlo Bo, ItalyCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==